Source link : https://newshealth.biz/health-news/mds-phase-3-trial-explores-novel-treatment-strategy/
Tamibarotene plus azacitidine for higher-risk myelodysplastic syndrome shows no added benefit in phase 3 trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/mds-phase-3-trial-explores-novel-treatment-strategy-2025a1000p60?src=rss Author : Publish date : 2025-09-22 13:03:00 Copyright for syndicated content belongs to the linked Source.
The post MDS: Phase 3 Trial Explores Novel Treatment Strategy first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-22 13:03:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8